Barely Significant

Excerpts

514,629 sentences

barely significantP = 0.020.4× alphagold
Despite this clear overlap, statistical analysis indicated that the synteny between mouse chromosome 4 loss and the human summary plots was either not significant (ALK-driven pHGG) or barely significant (NTRK2-driven pHGG; P = 0.02), as a result of the small human patient population harboring chromosomal aberrations.
highly significantp = 0.020.4× alphaqualifiedgold
ADONIS test on strain-level data showed highly significant effects of sampling location, metal concentrations, and their interactions (F = 1.36, p = 0.02), indicating that heavy metals are important drivers of variation in microbial community structure and that their influence differs among technogenic zones.
However, upon conducting multiple comparison tests, we found only one marginally statistically significant effect, such that the scientific evidence condition decreased intentions to wear a mask ( mean difference = −0.17, 95% CI [−0.31, −0.03], p = .02); which was in the opposite direction of our hypothesis.
nominally significantP = 0.020.4× alphagold
Although this difference in proportions was nominally significant (uncorrected P = 0.02), we did not see this effect in the equivalent analysis in the WGS cohort, where the proportion of HRCGS genes with more variants in ALS patients was indistinguishable from non-HRCGS genes (54% or 30 of 56 vs. 52% or 4,151 of 8,017, P = 0.089).
Retromer dysfunction in amyotrophic lateral sclerosis.
Proc Natl Acad Sci U S A · 2022 · PMC9245686
a significant trendP = 0.020.4× alphagold
When different types of dairy consumption were investigated separately for CVD, CHD, fracture, or all-cause mortality events, a significant trend of lower risk of fracture with increasing total fermented dairy consumption (adjusted model P = 0.02) was observed, with HR of 0.67 (95% CI: 0.50–0.90) for the highest (total fermented dairy>133 g/week) vs lowest (0≤total fermented dairy≤26, g/week) quartiles of total fermented dairy consumption ( Table 3 ).
a strong trendp = 0.020.4× alphagold
Results showed a strong trend toward improved survival [hazard ratio (HR) 0.60, p = 0.02) in patients who received MVAC. 6 Because of the high incidence of adverse effects such as myelosuppression in patients taking MVAC, dose-dense MVAC (ddMVAC) was introduced which delivered the drug in two weekly cycles with growth factor support to abrogate this side effect. ddMVAC was well tolerated, with a ypT0 rate of 38% in one trial which included node-positive patients. 7 Numerous other trials were conducted in this space over the decades, some of which we have summarized below.